707 SP 7.5 (Univasc 7.5 mg)
Generic Name: moexipril
Pill with imprint 707 SP 7.5 is Pink, Round and has been identified as Univasc 7.5 mg. It is supplied by Schwarz Pharma.
Univasc is used in the treatment of diabetic kidney disease; heart attack; heart failure; high blood pressure; left ventricular dysfunction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Univasc 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 707 SP 7.5
Univasc
- Generic Name
- moexipril
- Imprint
- 707 SP 7.5
- Strength
- 7.5 mg
- Color
- Pink
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schwarz Pharma
- National Drug Code (NDC)
- 00091-3707
- Inactive Ingredients
-
lactose, magnesium oxide, crospovidone, magnesium stearate, gelatin, hydroxypropyl cellulose (type h), hypromelloses, polyethylene glycol 6000, titanium dioxide, ferric oxide red
Note: Inactive ingredients may vary.
More about Univasc (moexipril)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 2 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
